General Information of the Compound
Compound ID
CP0961096
Compound Name
(4S,7S,13S,16S,19S,22S,25S,28S,31S)-4-((5S,8S,11S,14S,17S,20S,23S,26S,29S,35S,38S,41S,45S,48S,51S,54S,57S,60S)-20-((1H-indol-3-yl)methyl)-1,64-diamino-48-(3-amino-3-oxopropyl)-8,14-bis(4-aminobutyl)-38,45-di-sec-butyl-5-carbamoyl-11,54-bis(3-guanidinopropyl)-23-((R)-1-hydroxyethyl)-17,26,35-tris(hydroxymethyl)-57-isopropyl-41,51-dimethyl-29-(2-(methylthio)ethyl)-7,10,13,16,19,22,25,28,31,34,37,40,44,47,50,53,56,59-octadecaoxo-6,9,12,15,18,21,24,27,30,33,36,39,43,46,49,52,55,58-octadecaazatetrahexacontan-60-ylcarbamoyl)-31-acetamido-19-(4-aminobutyl)-22-sec-butyl-13,28-bis(2-carboxyethyl)-7-(3-guanidinopropyl)-16-isobutyl-25-isopropyl-6,9,12,15,18,21,24,27,30-nonaoxo-5,8,11,14,17,20,23,26,29-nonaazatetratriacontane-1,34-dioic acid
    Show/Hide
Formula
C149H258N46O43S
Molecular Weight
3414.049
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(C)C)[C@@H](C)CC)C(C)C)C(=O)NC[C@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)CC
    Show/Hide
InChI
InChI=1S/C149H258N46O43S/c1-18-78(10)116(141(233)167-68-81(13)121(213)192-117(79(11)19-2)145(237)189-104(72-196)124(216)169-71-109(203)173-101(56-65-239-17)133(225)187-106(74-198)140(232)195-119(83(15)199)146(238)186-103(67-85-69-166-87-37-22-21-36-86(85)87)138(230)188-105(73-197)139(231)179-91(40-25-30-59-152)128(220)178-95(45-35-64-165-149(161)162)129(221)176-90(39-24-29-58-151)127(219)174-88(120(156)212)38-23-28-57-150)193-136(228)98(46-51-107(155)201)175-122(214)82(14)170-125(217)94(44-34-63-164-148(159)160)183-142(234)114(76(6)7)190-134(226)93(42-27-32-61-154)177-132(224)99(49-54-112(208)209)181-126(218)89(43-33-62-163-147(157)158)172-108(202)70-168-123(215)96(47-52-110(204)205)180-137(229)102(66-75(4)5)185-130(222)92(41-26-31-60-153)184-144(236)118(80(12)20-3)194-143(235)115(77(8)9)191-135(227)100(50-55-113(210)211)182-131(223)97(171-84(16)200)48-53-111(206)207/h21-22,36-37,69,75-83,88-106,114-119,166,196-199H,18-20,23-35,38-68,70-74,150-154H2,1-17H3,(H2,155,201)(H2,156,212)(H,167,233)(H,168,215)(H,169,216)(H,170,217)(H,171,200)(H,172,202)(H,173,203)(H,174,219)(H,175,214)(H,176,221)(H,177,224)(H,178,220)(H,179,231)(H,180,229)(H,181,218)(H,182,223)(H,183,234)(H,184,236)(H,185,222)(H,186,238)(H,187,225)(H,188,230)(H,189,237)(H,190,226)(H,191,227)(H,192,213)(H,193,228)(H,194,235)(H,195,232)(H,204,205)(H,206,207)(H,208,209)(H,210,211)(H4,157,158,163)(H4,159,160,164)(H4,161,162,165)/t78-,79-,80-,81-,82-,83+,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,114-,115-,116-,117-,118-,119-/m0/s1
    Show/Hide
InChIKey
QWFNZELIDPJFKC-HKPRUFMOSA-N
Physicochemical Property
logP
-14.40829
Rotatable Bonds
125
Heavy Atom Count
239
Polar Areas
1491.79
Hydrogen Bond Donor Count
54
Hydrogen Bond Acceptor Count
48
Complexity
239

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4747756
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05999, Relaxin receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000708 OVCAR-5 Homo sapiens (Human)  1
1
EC50 = 124 nM
   TI
   LI
   LO
   TS